.

Deeper Knowledge, Faster

  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Medtronic
Baxter
QuintilesIMS
UBS
Cerilliant
Healthtrust
Boehringer Ingelheim
Merck
Cantor Fitzgerald

Generated: June 29, 2017

DrugPatentWatch Database Preview

NOVAMINE 15% Drug Profile

« Back to Dashboard

What is the patent landscape for Novamine 15%, and when can generic versions of Novamine 15% launch?

Novamine 15% is a drug marketed by Hospira Inc and Baxter Hlthcare and is included in two NDAs.

The generic ingredient in NOVAMINE 15% is amino acids. There are three hundred and thirty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.

Summary for Tradename: NOVAMINE 15%

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NOVAMINE 15% at DailyMed

Pharmacology for Tradename: NOVAMINE 15%

Ingredient-typeAmino Acids
Drug ClassAmino Acid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
NOVAMINE 15%
amino acids
INJECTABLE;INJECTION017957-004Nov 28, 1986DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER
amino acids
INJECTABLE;INJECTION020107-001Feb 5, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Daiichi Sankyo
Novartis
Accenture
UBS
Merck
Harvard Business School
Julphar
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot